Certificate of Supplementary Protection Regulations, SOR/2017-165

Section 2

Variations

Cite as Certificate of Supplementary Protection Regulations, SOR/2017-165, s. 2 · current to July 24, 2025 · regulation last amended January 1, 2025

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

For the purposes of subsections 105(3) and (4) of the Act, the prescribed variations are (a) a variation in any appendage within the molecular structure of a medicinal ingredient that causes it to be an ester, salt, complex, chelate, clathrate or any non-covalent derivative; (b) a variation that is an enantiomer, or a mixture of enantiomers, of a medicinal ingredient; (c) a variation that is a solvate or polymorph of a medicinal ingredient; (d) an in vivo or in vitro post-translational modification of a medicinal ingredient; and (e) any combination of the variations set out in paragraphs (a) to (d).
Read the Certificate of Supplementary Protection Regulations on the Justice Laws Website ↗

Made under Patent Act, R.S.C. 1985, c. P-4.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.